ALOXI® Reimbursement

Please note: When billing ALOXI using J2469, the billing unit is 25 mcg.
ALOXI should be billed at 10 units for a 0.25 mg dose.

ICD-9-CM Diagnosis Codes:
International Classification of Diseases, 9th Revision, Clinical Modification

These codes describe the patient’s diagnosis and must be present. All insurers require diagnosis codes to determine that services provided are appropriate and medically necessary. Billing codes should be as highly specific and relevant as possible.

Diagnosis Codes* Relevant to Reimbursement of Aloxi:

ICD-9 Code Description   ICD-9 # Code
Chemotherapy Encounter  
V58.11
Nausea and Vomiting  
787.01
Nausea Alone  
787.02
Vomiting Alone  
787.03

*Check with your local payor to ensure appropriate coding, as it may vary.

The provider will have to supply a primary diagnosis code to identify the type of cancer for which the patient is being treated.

New CPT Codes* for use on CMS 1500 with Medicare Part B

CPT Procedure Description   CPT Code
Additional sequential infusion up to one hour  
90767
Concurrent infusion  
90768
Each additional sequential push  
90775

CPT=Current Procedural Terminology Codes.
Enter appropriate CPT code based on route of administration.
*Effective January 1, 2006, under Medicare Part B.


Please see the accompanying full prescribing information.

*ALOXI is used in adults to help prevent the nausea and vomiting that can happen on the day of treatment with certain chemotherapies or occur days later following certain chemotherapies moderately likely to cause nausea and vomiting.

Tell your healthcare professional if you are taking other medications or if you have or develop severe heartbeat changes. The most common side effects of ALOXI are headache and constipation. ALOXI is available by prescription only. For more information, please see the Patient Product Information for ALOXI.

This site does not contain everything that is known about ALOXI. If you would like to know more, talk to your healthcare professional.